EXPERIMENTAL STUDIES
Effects of folate supplementation in hyperhomocysteinemic pigs
Pierre Ambrosi, MD*,
Pierre H. Rolland, PhD ,
Heidi Bodard, PhD ,
André Barlatier, PhD ,
Philippe Charpiot, PhD ,
Gwladys Guisgand, BSc ,
Alain Friggi, PhD ,
Odette Ghiringhelli, BSc ,
Gilbert Habib, MD*,
Gilles Bouvenot, MD ,
Danielle Garçon, PhD and
Roger Luccioni, MD, FACC*
* Department of Cardiology, Hôpital de la Timone, Marseille, France
INSERM CJF 94-01, Marseille, France
Laboratory of Biochemistry, Faculté de Pharmacie, Marseille, France
Laboratory of Therapeutics, Faculté de Médecine, Marseille, France
Manuscript received March 4, 1998;
revised manuscript received January 29, 1999,
accepted March 15, 1999.
Reprint requests and correspondence: Dr. Pierre Ambrosi, Department of Cardiology, Hôpital de la Timone, 13385 Marseille, France
OBJECTIVES
The aim of this study was to evaluate the therapeutic effects of folic acid in the pig model of hyperhomocysteinemia.
BACKGROUND
We have previously shown that pigs fed a methionine-rich diet develop hyperhomocysteinemia, arterial lesions and thrombotic events. Elevated homocysteine level is an independent risk factor for atherosclerosis that can be markedly lowered with daily folic acid administration. However, it is not known whether this treatment can prevent arterial lesions.
METHODS
Three groups of pigs were studied: 8 control subjects received a standard diet; 8 received a methionine-rich diet for four months; 8 received a methionine-rich diet for 1 month and then the methionine-rich diet + 5 mg/day folic acid for 3 months. At month 4 after hemodynamic investigation, all the pigs were sacrificed.
RESULTS
Control animals developed few usual vascular streaks. All the pigs fed a methionine-rich diet without folic acid treatment developed hyperhomocysteinemia (10.3 ± 1.3 µmol/liter at basal state, 18.2 ± 2.5 µmol/liter at one month and 14.6 ± 3.8 µmol/liter at four months), hemodynamic abnormalities and diffuse arterial lesions with smooth muscle cell hyperplasia, endothelial alterations and elastic lamina dislocation. In this group, one pig died of venous thromboembolism and one of myocardial infarction. The pigs fed a methionine-rich diet + folic acid displayed similar arterial lesions and two had thrombotic events (one myocardial infarction and one pulmonary embolism), despite normalization of homocysteine levels (10.9 ± 1.3 µmol/liter at basal state, 19.5 ± 2.5 µmol/liter at one month and 11.4 ± 3.8 µmol/liter at four months).
CONCLUSIONS
In the pig model of hyperhomocysteinemia, 5 mg/day folic acid did not prevent arterial lesions or thrombotic events.
|
Abbreviations and Acronyms
| | M0 | = basal state | | M1 | = month 1 | | M4 | = month 4 | | C group | = control group | | M group | = pigs receiving a methionine-rich diet | | M+F group | = pigs receiving a methionine-rich diet+folates | | D | = external arterial diameter | | P | = blood pressure | | Q | = blood flow |
|
This article has been cited by other articles:

|
 |

|
 |
 
C. Liu, Q. Wang, H. Guo, M. Xia, Q. Yuan, Y. Hu, H. Zhu, M. Hou, J. Ma, Z. Tang, et al.
Plasma S-Adenosylhomocysteine Is a Better Biomarker of Atherosclerosis Than Homocysteine in Apolipoprotein E-Deficient Mice Fed High Dietary Methionine
J. Nutr.,
February 1, 2008;
138(2):
311 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Selhub
The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
J. Nutr.,
June 1, 2006;
136(6):
1726S - 1730S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Durga, L. J. H. van Tits, E. G. Schouten, F. J. Kok, and P. Verhoef
Effect of Lowering of Homocysteine Levels on Inflammatory Markers: A Randomized Controlled Trial
Arch Intern Med,
June 27, 2005;
165(12):
1388 - 1394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Shoveller, J. D. House, J. A. Brunton, P. B. Pencharz, and R. O. Ball
The Balance of Dietary Sulfur Amino Acids and the Route of Feeding Affect Plasma Homocysteine Concentrations in Neonatal Piglets
J. Nutr.,
March 1, 2004;
134(3):
609 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Troen, E. Lutgens, D. E. Smith, I. H. Rosenberg, and J. Selhub
The atherogenic effect of excess methionine intake
PNAS,
December 9, 2003;
100(25):
15089 - 15094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Thambyrajah, M. J. Landray, H. J. Jones, F. J. McGlynn, D. C. Wheeler, and J. N. Townend
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
J. Am. Coll. Cardiol.,
June 1, 2001;
37(7):
1858 - 1863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Chambers, P. M. Ueland, O. A. Obeid, J. Wrigley, H. Refsum, and J. S. Kooner
Improved Vascular Endothelial Function After Oral B Vitamins : An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine
Circulation,
November 14, 2000;
102(20):
2479 - 2483.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|